Press Releases

Press Releases

Nov 08, 2017
GAITHERSBURG, Md. , Nov. 08, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced the Company will present at the Stifel 2017 Healthcare Conference. Presentation details are as follows: Date: Wednesday, November 15, 2017 Time: 1:15 p.m. – 1:55 p.m....
Nov 07, 2017
GAITHERSBURG, Md. , Nov. 07, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced its financial results for the third quarter and nine months ended September 30, 2017 . Third Quarter Achievements: Novavax initiated a Phase 1/2 clinical trial of its nanoparticle influenza vaccine...
Oct 13, 2017
GAITHERSBURG, Md. , Oct. 13, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) announced today that Barclay A. “Buck” Phillips has submitted his resignation as Senior Vice President, Chief Financial Officer (CFO) and Treasurer, to pursue an expanded opportunity in the industry. Mr....
Sep 19, 2017
GAITHERSBURG, Md. , Sept. 19, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced the Company will present at the Ladenburg Thalmann 2017 Healthcare Conference. Presentation details are as follows: Date: Tuesday, September 26, 2017 Time: 11:00 – 11:25 am ET Location: Track 5,...
Sep 19, 2017
Recently published NanoFlu™ preclinical data provide strong rationale for Phase 1/2 clinical trial based on robust antibody titers and improved protective responses against both current and drifted strains Data from trial expected by the end of 2017 GAITHERSBURG, Md. , Sept....
Sep 05, 2017
GAITHERSBURG, Md. , Sept. 05, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced the Company will participate in Citi’s 12 th Annual Biotech Conference . Conference details are as follows: Date: Thursday, September 7, 2017 Location: Mandarin Oriental hotel, Boston, MA About...
Aug 08, 2017
GAITHERSBURG, Md. , Aug. 08, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2017 . Second Quarter and Subsequent Achievements: Novavax’ nanoparticle flu vaccine demonstrates superior immunogenicity and...
Displaying 1 - 10 of 22